Use of sacubitril/valsartan in patients with heart failure: evidence from the real world-Reference-Cited by-同舟云学术

Use of sacubitril/valsartan in patients with heart failure: evidence from the real world

Published:2023-12-05 Issue:18 Volume:24 Page:2211-2219
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Valladales-Restrepo Luis Fernando¹²³,Sánchez-Ramírez Nicolás¹,Usma-Valencia Andrés Felipe¹,Velásquez-Quirama Santiago³,Henao-Martínez Manuela³,Castro-Rodriguez Jorge Alejandro¹,Gaviria-Mendoza Andrés¹²,Machado-Duque Manuel Enrique¹²,Machado-Alba Jorge Enrique¹^ORCID

Affiliation:

1. Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira, Risaralda, Colombia

2. Grupo de Investigación Biomedicina, Facultad de Medicina, Fundación Universitaria Autónoma de las Américas, Pereira, Colombia

3. Semillero de Investigación en Farmacología Geriátrica, Grupo de Investigación Biomedicina, Facultad de Medicina, Fundación Universitaria Autónoma de las Américas, Pereira, Risaralda, Colombia

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2023.2287667

Reference44 articles.

1. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

2. Global burden of heart failure: a comprehensive and updated review of epidemiology

3. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017

4. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

5. Reviewing the Modern Therapeutical Options and the Outcomes of Sacubitril/Valsartan in Heart Failure